Cytek Biosciences (CTKB) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed Cytek Biosciences (CTKB) over the past year, gaining 94.3% versus a gain of 40.9%. Over five years, CTKB leads with a -77.8% price change compared with -88.8% for PACB. Pacific Biosciences of California is the larger company by market cap ($845.5 million vs $694.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTKB | PACB |
|---|---|---|
| Share price | $5.34 | $2.72 |
| Market cap | $694.11M | $845.46M |
| 1-day change | -0.74% | +0.74% |
| YTD return | +5.74% | +45.45% |
| 1-year return | +40.90% | +94.29% |
| 5-year return | -77.81% | -88.85% |
| Forward P/E | 76.29 | — |
| EPS (TTM) | $-0.62 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.21 | $3.44 |
| 52-week low | $3.31 | $1.07 |
| Distance from 52-week high | -14.01% | -20.93% |
| Average volume | 1.03M | 9.85M |
| Shares outstanding | 129.98M | 310.83M |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACB has outperformed CTKB by 53.4 percentage points over the past year.
CTKB vs PACB FAQ
Which is bigger, Cytek Biosciences or Pacific Biosciences of California?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $845.46M compared with $694.11M for Cytek Biosciences (CTKB).
Which stock has performed better over the past year, CTKB or PACB?
PACB returned +94.29% over the past 12 months, compared with +40.90% for CTKB (price return, excluding dividends). Past performance does not predict future results.
Are Cytek Biosciences and Pacific Biosciences of California in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.